Fig. 5
From: Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
Survival curves after immunotherapy (anti-PD-L1 and/or anti-TIGIT) and fractionated radiotherapy (RT) in CT26 model. Survival curves of mice treated with 3x8Gy (a), 18x2Gy (b) with IgG or anti-PD-L1 and/or anti-TIGIT. X axes express the number of days since the beginning of RT. Y axes express the percentage survival of mice in each group. Experimental groups contained at least 10 mice per group. Log-rank test was used